Showing results (611-620 of 653) with videos related to
Sort By:
Pageof 66
Science Translational Medicine|December 1, 2021
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type CJohn V Pluvinage, Jerry Sun, Christel Claes, et al.British Journal of Haematology|November 18, 2020
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinibJorge J Castillo, Jithma P Abeykoon, Joshua N Gustine, et al.Leukemia|September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemiaJorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.Elife|January 11, 2019
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disordersCheen Euong Ang, Qing Ma, Orly L Wapinski, et al.Nature Methods|May 29, 2019
HiChIRP reveals RNA-associated chromosome conformationMaxwell R Mumbach, Jeffrey M Granja, Ryan A Flynn, et al.Journal of Medicinal Chemistry|December 4, 2010
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agentRupa S Shetty, Younghee Lee, Bin Liu, et al.Nature|July 6, 2018
Retraction Note: DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functionsWendy Huang, Benjamin Thomas, Ryan A Flynn, et al.Nature|August 6, 2025
RNA N-glycosylation enables immune evasion and homeostatic efferocytosisVincent R Graziano, Jennifer Porat, Marie Dominique Ah Kioon, et al.Nature|December 18, 2015
DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functionsWendy Huang, Benjamin Thomas, Ryan A Flynn, et al.Pageof 66